Market Research Report
Global Synoptophore Market Size, Share & Trends Analysis Report By Application(Diagnostic, Therapeutic), By Type (Manual, Automated), By End-user (Hospitals, Clinics), Regional Forecasts 2021-2027
|Global Synoptophore Market Size, Share & Trends Analysis Report By Application(Diagnostic, Therapeutic), By Type (Manual, Automated), By End-user (Hospitals, Clinics), Regional Forecasts 2021-2027|
Published: August 26, 2021
Bizwit Research & Consulting LLP
Delivery time: 2-3 business days
Global Synoptophore Market is valued approximately at USD 217.25 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.6% over the forecast period 2021-2027. Synoptophore is a specialized diagnosis and correction device used to cure strabismus, often known as squint, in the eyes. Strabismus is caused by an imbalance in the muscle that regulates eye movement. As a result, the eye alignment is set out, and the condition of eye turning out (diverge) or eye turning in develops (converge). It can also occur as a result of hypertropia or hypotropia. Some of the primary factors driving the market's growth include the rising incidence of visual acuity diseases such as amblyopia, strabismus, diplopia, and other convergence insufficiency ailments. Amblyopia affects around 1-5 percent of the world's population, according to the American Academy of Ophthalmology. Furthermore, Increasing prevalence of ocular disorder propel the market in the upcoming years. For instance, According to Dovepress's current estimates, 285 million individuals worldwide are impacted by vision disabilities, including 39 million blind persons and 246 million with subnormal vision.. However, availability of alternative diagnostic device may impede market growth over the forecast period of 2021-2027.
North America had the highest revenue share and anticipated to continue during the projection period. Its largest market share is due to the existence of significant market players, the rising prevalence of strabismus and amblyopia, and the growing preference for non-surgical treatment techniques. However, Europe accounted for a significant portion of the market share and is anticipated to continue to expand at a considerable rate during the forecast period. The expanding number of local manufacturers of ocular diagnostic devices, as well as increased awareness of sophisticated technologies in ophthalmic care, are likely to propel the market further.
Major market player included in this report are:
Gem Optical Instruments Industries.
Takagi Seiko Co., Ltd.
Shanghai Link Instrument Co. Ltd.
VISION-TECH CO., LTD.
Nanjing Redsun Optical Co., Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By End use:
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.
Target Audience of the Global Synoptophore Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers
List of figures